The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

BTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...

Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating ...

BTIG analyst Clark Lampen raised the firm’s price target on DraftKings (DKNG) to $64 from $59 and keeps a Buy rating on the shares. The firm says ...

When U.S. investors return from the long weekend they will be faced with a stock market looking well-positioned to break out to fresh record highs. But any such move into virgin territory may precede ...

Elon Musk’s 97-billion-dollar bid for OpenAI was soundly rejected by the artificial intelligence startup, which said the company “is not for sale.” ...